What happens when you take valproate with biotin?
Valproate (valproic acid, sodium valproate, divalproex; brand names Depakote, Depakene, Depacon) is a workhorse anticonvulsant that also doubles as a mood stabilizer for bipolar disorder and a preventive for migraine. One of its most visible long-term side effects — affecting an estimated 10 to 30 percent of users to some degree — is hair thinning or hair loss (alopecia), and growing evidence ties this in part to disrupted biotin metabolism.
The proposed mechanism is different from the enzyme-induction story that drives biotin loss with carbamazepine, phenobarbital, and phenytoin. Valproate is not a strong CYP inducer. Instead, valproate appears to impair biotinidase activity — the enzyme that recycles biotin from biocytin (the lysine-biotin conjugate left over after carboxylases are degraded) and that also releases dietary protein-bound biotin in the gut. Studies in children on valproate monotherapy have documented significantly lower serum biotinidase activity than in untreated controls, and rat studies have replicated the finding and shown that biotin supplementation can restore both enzyme activity and hair regrowth.
Valproate is also known to disrupt mitochondrial function, and several biotin-dependent carboxylases (pyruvate carboxylase, propionyl-CoA carboxylase, methylcrotonyl-CoA carboxylase) live in the mitochondria. Functional impairment of these enzymes shows up biochemically as elevated urinary 3-hydroxyisovaleric acid, a marker that has been observed in valproate users at higher rates than in matched controls.
Why is this important?
Biotin (vitamin B7) is a coenzyme for five carboxylases central to fatty-acid synthesis, gluconeogenesis, amino-acid catabolism, and propionate metabolism. Frank deficiency causes seborrheic dermatitis, alopecia, brittle nails, conjunctivitis, depression, paresthesias, and — in severe cases — encephalopathy and seizures. Subclinical insufficiency is more common and may contribute to the cosmetic side effects of valproate that often drive patients (especially younger adults and women) to discontinue an otherwise effective medication.
The hair-loss connection has practical importance. Several case reports and small clinical series describe valproate-related hair loss reversing with biotin supplementation (typically 5 to 10 mg per day) without needing to discontinue or switch the anticonvulsant. That is a meaningful win for patients whose seizures or mood are otherwise well controlled on valproate.
Pediatric epilepsy practice is particularly attentive to biotin and zinc status in valproate users because of the documented effect on biotinidase and because biotinidase deficiency is itself a treatable cause of infantile seizures — clinicians want to keep biotin in mind so that nutritional contributions to a patient's symptoms are not missed.
What should you do?
If you are on valproate and noticing hair thinning, brittle nails, or skin changes, talk with your prescriber about a trial of biotin supplementation. A reasonable starting point is a B-complex multivitamin (often 30 to 100 mcg of biotin) or a low-dose standalone biotin supplement (300 mcg to 1 mg). For visible hair loss, some clinicians use higher doses (5 to 10 mg daily) for a defined trial period of three to six months; biotin has no established upper safety limit.
The main caution is laboratory interference. High-dose biotin (5 mg+) can produce falsely low or falsely high results on many biotin-streptavidin-based immunoassays, including thyroid panels (TSH, free T4), troponin (used to diagnose heart attacks), parathyroid hormone, vitamin D, and reproductive hormones. The FDA has issued a specific alert. If you are taking high-dose biotin, stop it at least 24 to 72 hours before scheduled lab draws and tell the lab.
Also worth knowing: valproate-related hair loss is sometimes linked to low zinc and selenium as well, so a multivitamin or B-complex with both biotin and zinc may be more effective than biotin alone. Track your dose and any hair, skin, or nail changes in Pilora across the months it takes to see results.
Do not adjust valproate doses on your own. If supplements do not help and hair loss is affecting your quality of life, talk with your prescriber about whether a switch to a different anticonvulsant or mood stabilizer is appropriate.
Which specific products are affected?
The interaction applies to all valproate-containing products: Depakote (divalproex sodium), Depakote ER, Depakote Sprinkles, Depakene, Depacon (IV), sodium valproate, valproic acid, and generic formulations. Both immediate-release and extended-release products affect biotin status. Carbamazepine, phenobarbital, primidone, and phenytoin also reduce biotin status, though through different mechanisms (enzyme induction and SMVT inhibition rather than biotinidase impairment).
On the supplement side, biotin is sold as standalone tablets (commonly 1 to 10 mg), in B-complex products (usually 30 to 100 mcg), in multivitamins (around 30 to 50 mcg), and in many "hair, skin, and nails" formulas (2.5 to 10 mg). For valproate-related insufficiency, lower doses are sensible for general supplementation and higher doses are sometimes used for a hair-loss trial.
The bottom line
Valproate appears to suppress biotinidase activity and impair mitochondrial biotin handling, contributing to the drug's signature hair loss and brittle nails in a meaningful share of users. A B-complex or low-dose biotin supplement is a reasonable hedge, and case reports show that biotin supplementation can reverse valproate-related alopecia without stopping the medication. Watch out for high-dose biotin interfering with thyroid, troponin, and other immunoassay lab results.